Hirobe S - Search Results

1

The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity.

Hirobe S, Imaeda K, Tachibana M, Okada N. Hirobe S, et al. Int J Mol Sci. 2022 Apr 6;23(7):4056. doi: 10.3390/ijms23074056. Int J Mol Sci. 2022. PMID: 35409419 Free PMC article.

2

Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria.

Hirobe S, Matsuo K, Quan YS, Kamiyama F, Morito H, Asada H, Takaya Y, Mukai Y, Okada N, Nakagawa S. Hirobe S, et al. Vaccine. 2012 Feb 27;30(10):1847-54. doi: 10.1016/j.vaccine.2011.12.130. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22230592 Free PMC article. Clinical Trial.

3

Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.

Matsuo K, Hirobe S, Yokota Y, Ayabe Y, Seto M, Quan YS, Kamiyama F, Tougan T, Horii T, Mukai Y, Okada N, Nakagawa S. Matsuo K, et al. Among authors: hirobe s. J Control Release. 2012 Jun 28;160(3):495-501. doi: 10.1016/j.jconrel.2012.04.001. Epub 2012 Apr 11. J Control Release. 2012. PMID: 22516091

4

Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system.

Hiraishi Y, Nakagawa T, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S. Hiraishi Y, et al. Among authors: hirobe s. Int J Pharm. 2013 Jan 30;441(1-2):570-9. doi: 10.1016/j.ijpharm.2012.10.042. Epub 2012 Nov 5. Int J Pharm. 2013. PMID: 23137695

5

Transcutaneous vaccines--current and emerging strategies.

Hirobe S, Okada N, Nakagawa S. Hirobe S, et al. Expert Opin Drug Deliv. 2013 Apr;10(4):485-98. doi: 10.1517/17425247.2013.760542. Epub 2013 Jan 15. Expert Opin Drug Deliv. 2013. PMID: 23316778 Review.

6

Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Matsuo K, Hirobe S, Okada N, Nakagawa S. Matsuo K, et al. Among authors: hirobe s. Vaccine. 2013 May 1;31(19):2403-15. doi: 10.1016/j.vaccine.2013.03.022. Epub 2013 Mar 21. Vaccine. 2013. PMID: 23523401 Free PMC article. Review.

7

Analysis of transcutaneous antigenic protein delivery by a hydrogel patch formulation.

Matsuo K, Ishii Y, Kawai Y, Saiba Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S. Matsuo K, et al. Among authors: hirobe s. J Pharm Sci. 2013 Jun;102(6):1936-1947. doi: 10.1002/jps.23540. Epub 2013 Apr 12. J Pharm Sci. 2013. PMID: 23585300

8

Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.

Hirobe S, Azukizawa H, Matsuo K, Zhai Y, Quan YS, Kamiyama F, Suzuki H, Katayama I, Okada N, Nakagawa S. Hirobe S, et al. Pharm Res. 2013 Oct;30(10):2664-74. doi: 10.1007/s11095-013-1092-6. Epub 2013 Jun 18. Pharm Res. 2013. PMID: 23775442 Clinical Trial.

9

Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.

Hiraishi Y, Hirobe S, Iioka H, Quan YS, Kamiyama F, Asada H, Okada N, Nakagawa S. Hiraishi Y, et al. Among authors: hirobe s. J Control Release. 2013 Oct 28;171(2):93-103. doi: 10.1016/j.jconrel.2013.06.008. Epub 2013 Jun 18. J Control Release. 2013. PMID: 23791975 Clinical Trial.

10

Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.

Matsuo K, Okamoto H, Kawai Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S. Matsuo K, et al. Among authors: hirobe s. J Neuroimmunol. 2014 Jan 15;266(1-2):1-11. doi: 10.1016/j.jneuroim.2013.11.002. Epub 2013 Nov 11. J Neuroimmunol. 2014. PMID: 24315156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters